Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab with Radiochemotherapy for Anal Cancer
NCT01581840Phase 2Completed
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Jan 2016
- Primary completion
- Sep 2018
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in anal squamous cell carcinoma (SCCA), sponsored by Fédération Francophone de Cancérologie Digestive. Started Jan 2016; status: completed.
02
Drugs
panitumumab
03
Conditions
anal squamous cell carcinoma (SCCA)
Beyond the preview
Go deeper on NCT01581840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01581840.